---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-23-026584"
form_type: "8-K"
ticker: "AQST"
cik: "0001398733"
company_name: "Aquestive Therapeutics, Inc."
filed_at: "2023-08-02T23:59:59+00:00"
generated_at: "2026-06-12T12:30:37.198358+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Aquestive raises $4.8M via warrant exercise; issues new warrants at $2.60 strike, expiring 2029

## Summary
- Exercise of 5M existing warrants at $0.96 yields ~$4.8M gross proceeds to Aquestive.
- Issued new warrants to purchase up to 2.75M shares at $2.60, expiring Feb 2, 2029.
- Company agreed to 30-day lock-up on further securities offerings and no variable-rate transactions.
- Beneficial ownership limitation on new warrants set at 4.99% (option to increase to 9.99%).
- Company to file resale registration statement for new warrant shares within 60 days.

## SEC filing metadata
- accession: 0001628280-23-026584
- form_type: 8-K
- ticker: AQST
- cik: 0001398733
- company_name: Aquestive Therapeutics, Inc.
- filed_at: 2023-08-02T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 1.01, 3.02, 3.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1398733/000162828023026584/0001628280-23-026584-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1398733/000162828023026584/aqst-20230801.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-23-026584
- JSON: https://secwatch.observer/filing/0001628280-23-026584.json
- Plain text: https://secwatch.observer/filing/0001628280-23-026584.txt

## Key facts
- Material Agreements
  Aquestive Therapeutics, Inc. entered into Letter Agreement valued at approximately $4,800,000.00 (effective 2023-08-01).
  - Action: entry
  - Agreement: equity purchase
  - Value: approximately $4,800,000.00
  - Effective: 2023-08-01
  source text: On August 1, 2023, the Company entered into an Inducement Offer to Exercise Common Stock Purchase Warrants letter agreement (the “Letter Agreement”) with the holder (the “Exercising Holder”) of 5,000,000 of the remaining Common Stock Warrants (the “Existing Warrants”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1398733/000162828023026584/0001628280-23-026584-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.